IP Library Granted Patent US 8,669,365
Granted Patent B2
US 8,669,365 · App. 12/199,722 · Granted Mar 11, 2014

Cyclopamine analogs

Inventors: Brian Austad (Tewksbury, MA); Mark L. Behnke (Somerville, MA); Alfredo C. Castro (Winchester, MA); André B. Charette (Longueuil, CA); Michael J. Grogan (Winchester, MA); Somarajannair Janardanannair (Woburn, MA); Andre Lescarbeau (Somerville, MA); Stephane Peluso (Somerville, MA); Martin Tremblay (Melrose, MA)
Assignee: Infinity Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,669,365
App. No.
12/199,722
Granted
Mar 11, 2014
Kind
B2
Abstract

The invention provides novel derivatives of cyclopamine having the following formula:

Claims (103)

1. A process for preparing a compound of formula 136:

wherein

Y is CR 7 R 8 ;

R 1 is H, alkyl, amino, hydroxyl, carboxyl, carbamoyl, alkoxy, hydroxyl, sugar or a protected hydroxyl group; R 2 is H, alkyl, alkenyl, alkynyl, nitrile, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 1 and R 2 taken together form ═O, ═S, ═N(OR 9 ), ═N(R 9 ), ═C(R 9 ) 2 , or ═N(N(R 9 ) 2 );

each of R 3 , R 4 , and R 5 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 3 and R 4 or R 4 and R 5 taken together form a bond;

R 6 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —OR 9 , —C(O)R 9 , —CO 2 R 9 , —SO 2 R 9 , —C(O)N(R 9 )(R 9 ), —[C(R 9 ) 2 ] q R 9 , —[(W)—N(R 9 )C(O)] q R 9 , —[(W)—C(O)] q R 9 , —[(W)—C(O)O] q R 9 , —[(W)—OC(O)] q R 9 , —[(W)—SO 2 ] q R 9 , —[(W)—N(R 9 )SO 2 ] q R 9 , —[(W)—C(O)N(R 9 )] q R 9 , —[(W)—O] q R 9 , —[(W)—N(R 9 )] q R 9 , —[(W)—S] q R 9 , or a nitrogen protecting group;

wherein each W independently for each occurrence is a diradical;

each q is independently 1, 2, 3, 4, 5, or 6;

each of R 7 and R 8 is, independently, H, alkyl, amido, halide, or ester; and

each R 9 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl;

said process comprising the step of:

contacting a compound of formula 136a with a haloalkylzinc phosphate cyclopropanating agent;

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are as defined above;

to form said compound of formula 136;

wherein said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid of formula 141a or salt thereof, a dialkylzinc, and a dihaloalkylane of formula 141b:

wherein

each of X and X′ is independently chloride, bromide, or iodide;

each of R 7 and R 8 is independently H, alkyl, halide, amido, or ester; and

each of R 10 and R 11 is independently alkyl, alkenyl, aralkyl, aryl, heteroaryl, or heteroaralkyl.

2. The process of claim 1 , wherein R 7 and R 8 are both H.

3. The process of claim 1 , wherein R 1 is a protected hydroxyl.

4. The process of claim 1 , wherein R 6 is a nitrogen protecting group.

5. The process of claim 1 ,

wherein each of R 10 and R 11 is independently aryl.

6. The process of claim 1 , wherein R 10 and R 11 are each 2,6-dimethylphenyl.

7. A process for preparing a compound of formula 137:

wherein

Y is CR 7 R 8 ;

R 1 is H, alkyl, amino, hydroxyl, carboxyl, carbamoyl, alkoxy, hydroxyl, sugar or a protected hydroxyl group; R 2 is H, alkyl, alkenyl, alkynyl, nitrile, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 1 and R 2 taken together form ═O, ═S, ═N(OR 9 ), ═N(R 9 ), ═C(R 9 ) 2 , or ═N(N(R 9 ) 2 );

each of R 3 , R 4 , and R 5 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 3 and R 4 or R 4 and R 5 taken together form a bond;

R 6 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —OR 9 , —C(O)R 9 , —CO 2 R 9 , —SO 2 R 9 , —C(O)N(R 9 )(R 9 ), —[C(R 9 ) 2 ] q R 9 , —[(W)—N(R 9 )C(O)] q R 9 , —[(W)—C(O)] q R 9 , —[(W)—C(O)O] q R 9 , —[(W)—OC(O)] q R 9 , —[(W)—SO 2 ] q R 9 , —[(W)—N(R 9 )SO 2 ] q R 9 , —[(W)—C(O)N(R 9 )] q R 9 , —[(W)—O] q R 9 , —[(W)—N(R 9 )] q R 9 , —[(W)—S] q R 9 , or a nitrogen protecting group;

each W independently for each occurrence is a diradical alkylene having 1-6 carbon atoms;

each q is independently 1, 2, 3, 4, 5, or 6;

each of R 7 and R 8 is, independently, H, alkyl, amido, halide, or ester;

each R 9 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl;

said process comprising the steps of:

contacting a compound of formula 137a with a haloalkylzinc phosphate cyclopropanating agent;

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are as defined above;

to form a compound with formula 137b

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and Y are as defined above; and

contacting said compound of formula 137b with an acid to give said compound of formula 137;

wherein said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid of formula 141a or salt thereof, a dialkylzinc, and a dihaloalkylane of formula 141b:

wherein

each of X and X′ is independently chloride, bromide, or iodide;

each of R 7 and R 8 is independently H, alkyl, halide, amido, or ester; and

each of R 10 and R 11 is independently alkyl, alkenyl, aralkyl, aryl, heteroaryl, or heteroaralkyl.

8. The process according to claim 7 ,

wherein

R 1 is a protected hydroxyl group;

R 2 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; and

R 6 is a nitrogen protecting group.

9. The process of claim 7 , wherein R 7 and R 8 are both H.

10. The process of claim 7 , wherein said protected hydroxyl group is an ester or a carbonate.

11. The process of claim 7 , wherein said nitrogen protecting group is a carbamate.

12. The process of claim 7 , wherein said nitrogen protecting group is an amide.

13. The process of claim 7 , wherein R 2 and R 3 are H and R 4 and R 5 taken together form a bond.

14. The process of claim 7 ,

wherein each of R 10 and R 11 is independently aryl.

15. The process of claim 7 , wherein said acid is acetic acid, trifluoromethanesulfonic acid, phosphoric acid, methanesulfonic acid or HCl.

16. The process of claim 7 , wherein said acid is BF 3 , zinc chloride, zinc methanesulfonate, or a zinc salt.

17. A process for preparing a compound of formula 156:

comprising the steps of:

contacting a compound of formula 156a with a haloalkylzinc phosphate cyclopropanating agent to form a compound formula 156b; and

and combining said compound of formula 156b with an acid to give said compound of formula 156;

wherein

R 1 is an oxygen protecting group selected from the group consisting of formate, acetate, chloroacetate, dichloroacetate, trichloroacetate, pivaloate, benzoates, alkyl carbonate, alkenyl carbonate, aryl carbonates, aralkyl carbonate, 2,2,2-trichloroethyl carbonate, alkoxymethyl ether, aralkoxymethyl ether, alkylthiomethyl ether, aralkylthio ether, arylthio ether, trialkylsilyl ether, alkylarylsilyl ether, benzyl ether, arylmethyl ether, allyl ether; and

R 2 is a nitrogen protecting group selected from the group consisted of formyl, chloroacetyl, trichloroacetyl, trifluoroacetyl, phenyl acetyl, benzoyl, alkyl carbamates, aralkyl carbamates, aryl carbamates, allyl, aralkyl, triarylmethyl, alkoxymethyl, aralkoxymethyl, N-2-cyanoethyl, diarylphosphinamides, dialkylphosphinamidates, diarylphosphinamidates, and trialkylsilyl;

wherein said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid of formula 158a or salt thereof, a dialkylzinc, and a dihaloalkylane of formula 158b:

wherein

each of X and X′ is independently chloride, bromide, or iodide;

each of R 7 and R 8 is independently H, alkyl, halide, amido, or ester; and

each of R 10 and R 11 is independently alkyl, alkenyl, aralkyl, aryl, heteroaryl, or heteroaralkyl.

18. The process of claim 17 ,

wherein each of R 10 and R 11 is, independently, aryl.

19. The process of claim 17 , wherein said oxygen protecting group is alkyl carbonate, aralkyl carbonate, benzoate, pivaloate, or formate.

20. The process of claim 17 , wherein said nitrogen protecting group is benzoyl, trichloroacetyl, trifluoroacetyl, formyl, alkyl carbamates, aralkyl carbamates, or aryl carbamates.

21. The process of claim 17 , wherein said oxygen protecting group is benzylcarbonate.

22. The process of claim 17 , wherein said nitrogen protecting group is benzylcarbamate.

23. The process of claim 7 , wherein R 10 and R 11 are each 2,6-dimethylphenyl.

24. The process of claim 17 , wherein R 10 and R 11 are each 2,6-dimethylphenyl.

25. A process for preparing a compound of formula 136:

wherein

Y is CR 7 R 8 ;

R 1 is H, alkyl, amino, hydroxyl, carboxyl, carbamoyl, alkoxy, hydroxyl, sugar or a protected hydroxyl group; R 2 is H, alkyl, alkenyl, alkynyl, nitrile, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 1 and R 2 taken together form ═O, ═N(OR 9 ), ═N(R 9 ), ═C(R 9 ) 2 , or ═N(N(R 9 ) 2 );

each of R 3 , R 4 , and R 5 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 3 and R 4 or R 4 and R 5 taken together form a bond;

R 6 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —OR 9 , —C(O)R 9 , —CO 2 R 9 , —SO 2 R 9 , —C(O)N(R 9 )(R 9 ), —[C(R 9 ) 2 ] q R 9 , —[(W)—N(R 9 )C(O)] q R 9 , —[(W)—C(O)] q R 9 , —[(W)—C(O)O] q R 9 , —[(W)—OC(O)] q R 9 , —[(W)—SO 2 ] q R 9 , —[(W)—N(R 9 )SO 2 ] q R 9 , —[(W)—C(O)N(R 9 )] q R 9 , —[(W)—O] q R 9 , —[(W)—N(R 9 )] q R 9 , —[(W)—S] q R 9 , or a nitrogen protecting group;

wherein each W independently for each occurrence is a diradical;

each q is independently 1, 2, 3, 4, 5, or 6;

each of R 7 and R 8 is, independently, H, alkyl, alkenyl, aryl, nitrile, amido, halide, or ester; and

each R 9 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl;

said process comprising the step of:

contacting a compound of formula 136a with a haloalkylzinc phosphate cyclopropanating agent;

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are as defined above;

to form said compound of formula 136;

wherein said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid of formula 141a or salt thereof, a dialkylzinc, and a dihaloalkylane of formula 141b:

wherein

each of X and X′ is independently chloride, bromide, or iodide;

each of R 7 and R 8 is independently H, alkyl, halide, amido, or ester; and

each of R 10 and R 11 is independently alkyl, alkenyl, aralkyl, aryl, heteroaryl, or heteroaralkyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: INFINITY PHARMACEUTICALS, INC.
To: ROYALTY SECURITY, LLC
Reel/Frame 051519/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2008
From: AUSTAD, BRIAN; BEHNKE, MARK L.; CASTRO, ALFREDO C.; CHARETTE, ANDRE B.; GROGAN, MICHAEL J.; JANARDANANNAIR, SOMARAJANNAIR; LESCARBEAU, ANDRE; PELUSO, STEPHANE; TREMBLAY, MARTIN
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 021464/0382 →
Continuity (4)
Continuation 11965688 · Dec 27, 2007
Provisional Application 60878018 · Dec 28, 2006
Provisional Application 60941596 · Jun 1, 2007
Related Publication 20090216022A1 · Aug 27, 2009